These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 17493855

  • 21. Designing of novel carbonic anhydrase inhibitors and activators.
    Supuran CT, Vullo D, Manole G, Casini A, Scozzafava A.
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):49-68. PubMed ID: 15328829
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Homology modeling and receptor-based 3D-QSAR study of carbonic anhydrase IX.
    Tuccinardi T, Ortore G, Rossello A, Supuran CT, Martinelli A.
    J Chem Inf Model; 2007 Jan; 47(6):2253-62. PubMed ID: 17949069
    [Abstract] [Full Text] [Related]

  • 26. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with fluorine-containing sulfonamides. The first subnanomolar CA IX inhibitor discovered.
    Vullo D, Scozzafava A, Pastorekova S, Pastorek J, Supuran CT.
    Bioorg Med Chem Lett; 2004 May 03; 14(9):2351-6. PubMed ID: 15081039
    [Abstract] [Full Text] [Related]

  • 27. QSAR studies for the inhibition of the transmembrane carbonic anhydrase isozyme XIV with sulfonamides using PRECLAV software.
    Singh S, Khadikar PV, Scozzafava A, Supuran CT.
    J Enzyme Inhib Med Chem; 2009 Apr 03; 24(2):337-49. PubMed ID: 18830873
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies.
    Güzel O, Temperini C, Innocenti A, Scozzafava A, Salman A, Supuran CT.
    Bioorg Med Chem Lett; 2008 Jan 01; 18(1):152-8. PubMed ID: 18024029
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Carbonic anhydrase inhibitors: purification and inhibition studies of pigeon (Columba livia var. domestica) red blood cell carbonic anhydrase with sulfonamides.
    Ozensoy O, Arslan M, Supuran CT.
    J Enzyme Inhib Med Chem; 2011 Oct 01; 26(5):749-53. PubMed ID: 21476925
    [Abstract] [Full Text] [Related]

  • 34. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition.
    Weber A, Casini A, Heine A, Kuhn D, Supuran CT, Scozzafava A, Klebe G.
    J Med Chem; 2004 Jan 29; 47(3):550-7. PubMed ID: 14736236
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Quantitative structure activity relationship studies of sulfamide derivatives as carbonic anhydrase inhibitor: as antiglaucoma agents.
    Kumar S, Singh V, Tiwari M.
    Med Chem; 2007 Jul 29; 3(4):379-86. PubMed ID: 17627576
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib.
    Di Fiore A, Pedone C, D'Ambrosio K, Scozzafava A, De Simone G, Supuran CT.
    Bioorg Med Chem Lett; 2006 Jan 15; 16(2):437-42. PubMed ID: 16290146
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.